This compound is a pharmaceutical intermediate featuring a complex aromatic structure with amide, ester, and ether functional groups. Its significance lies in its role as a building block for the synthesis of other chemical entities.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2204442-52-2
N,N'-Bis[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
research compound
2,4-Dimethyl-5-nitrobenzoic acid
Pharmaceutical intermediate
5-Fluoro-2-methylbenzaldehyde
Pharmaceutical intermediate
1-Benzylpiperidine-4-carbaldehyde
pharmaceutical intermediate
Methyl 5-chloro-6-methoxynicotinate
pharmaceutical intermediate
4,4'-(((carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(oxy))bis(N-methylpicolinamide)
Regorafenib impurity reference standard
methyl 4-[4-[[4-[[2-(methylcarbamoyl)-4-pyridinyl]oxy]phenyl]carbamoylamino]phenoxy]pyridine-2-carboxylate
LYFLMAXULJNQKQ-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=CC(=NC=C4)C(=O)OC